FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.1  |  FHIR Version n/a  User: [n/a]

929360081000036101: Medicinal product pack reference set (foundation metadata concept)


Status: current, Primitive. Date: 31-Mar 2011. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3288201000168119 MPP (medicinal product pack) reference set en Synonym Active Case sensitive Australian Medicines Terminology module
965507131000036117 Medicinal product pack reference set en Synonym Active Case sensitive Australian Medicines Terminology module
965507141000036110 Medicinal product pack reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4351131000168114 <p>Terminology to describe in a health record an abstract concept representing the properties of one or more quantitatively and clinically equivalent Trade Product Packs.</p><p>This reference set supports the accurate and unambiguous electronic communication and exchange of medicines information between clinicians for medication management and the recording of adverse reactions.</p><p><b>Target client: </b>NCTS</p> en Definition Active Case sensitive Australian Medicines Terminology module


15976 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Medicinal product pack reference set Has licence SNOMED CT-AU licence​ true Inferred relationship Some 1740441059
Medicinal product pack reference set Developed by Australian Digital Health Agency true Inferred relationship Some 991480534
Medicinal product pack reference set Is a Simple type reference set true Inferred relationship Some

Members
lapatinib 250 mg tablet, 140
lapatinib 250 mg tablet, 30
lapatinib 250 mg tablet, 70
lapatinib 250 mg tablet, 84
laronidase 500 units/5 mL injection, 5 mL vial
larotrectinib 100 mg capsule, 56
larotrectinib 20 mg/mL oral liquid, 100 mL
larotrectinib 20 mg/mL oral liquid, 2 x 50 mL
larotrectinib 20 mg/mL oral liquid, 50 mL
larotrectinib 25 mg capsule, 56
latanoprost 0.005% + timolol 0.5% eye drops, 2.5 mL
latanoprost 0.005% + timolol 0.5% eye drops, 3 x 2.5 mL
latanoprost 0.005% eye drops, 1 mL
latanoprost 0.005% eye drops, 2.5 mL
latanoprost 0.005% eye drops, 3 x 2.5 mL
latanoprost 0.005% eye drops, 6 x 2.5 mL
lauromacrogol-400 0.5% (10 mg/2 mL) injection, 5 x 2 mL ampoules
lauromacrogol-400 1% (20 mg/2 mL) injection, 5 x 2 mL ampoules
lauromacrogol-400 2% (40 mg/2 mL) injection, 5 x 2 mL ampoules
lauromacrogol-400 3% (60 mg/2 mL) injection, 5 x 2 mL ampoules
sodium citrate dihydrate 450 mg/5 mL + lauryl sulfoacetate sodium 45 mg/5 mL + sorbitol 3.125 g/5 mL enema, 12 x 5 mL
sodium citrate dihydrate 450 mg/5 mL + lauryl sulfoacetate sodium 45 mg/5 mL + sorbitol 3.125 g/5 mL enema, 4 x 5 mL
sodium citrate dihydrate 450 mg/5 mL + lauryl sulfoacetate sodium 45 mg/5 mL + sorbitol 3.125 g/5 mL enema, 50 x 5 mL
ledipasvir 90 mg + sofosbuvir 400 mg tablet, 28
leflunomide 10 mg tablet, 10
leflunomide 10 mg tablet, 30
leflunomide 100 mg tablet [3] (&) leflunomide 20 mg tablet [30], 1 pack
leflunomide 100 mg tablet, 3
leflunomide 20 mg tablet, 10
leflunomide 20 mg tablet, 30
lemborexant 10 mg tablet, 28
lemborexant 5 mg tablet, 28
lemborexant 5 mg tablet, 3
lenacapavir 300 mg tablet, 5
lenacapavir 463.5 mg/1.5 mL injection, 2 x 1.5 mL vials
lenalidomide 10 mg capsule, 14
lenalidomide 10 mg capsule, 21
lenalidomide 10 mg capsule, 28
lenalidomide 15 mg capsule, 14
lenalidomide 15 mg capsule, 21
lenalidomide 15 mg capsule, 28
lenalidomide 2.5 mg capsule, 14
lenalidomide 2.5 mg capsule, 21
lenalidomide 2.5 mg capsule, 28
lenalidomide 20 mg capsule, 14
lenalidomide 20 mg capsule, 21
lenalidomide 20 mg capsule, 28
lenalidomide 25 mg capsule, 14
lenalidomide 25 mg capsule, 21
lenalidomide 25 mg capsule, 28
lenalidomide 5 mg capsule, 14
lenalidomide 5 mg capsule, 21
lenalidomide 5 mg capsule, 28
lenalidomide 7.5 mg capsule, 14
lenalidomide 7.5 mg capsule, 21
lenalidomide 7.5 mg capsule, 28
lenograstim 13.4 million units (105 microgram) injection, 1 vial
lenograstim 33.6 million units (263 microgram) injection, 1 vial
lenvatinib 10 mg capsule, 30
lenvatinib 4 mg capsule, 30
lepirudin 50 mg injection, 1 vial
lepirudin 50 mg injection, 10 vials
lercanidipine hydrochloride 10 mg tablet, 100
lercanidipine hydrochloride 10 mg tablet, 14
lercanidipine hydrochloride 10 mg tablet, 28
lercanidipine hydrochloride 10 mg tablet, 30
lercanidipine hydrochloride 10 mg tablet, 500
lercanidipine hydrochloride 10 mg tablet, 7
lercanidipine hydrochloride 20 mg tablet, 100
lercanidipine hydrochloride 20 mg tablet, 14
lercanidipine hydrochloride 20 mg tablet, 28
lercanidipine hydrochloride 20 mg tablet, 30
lercanidipine hydrochloride 20 mg tablet, 500
lercanidipine hydrochloride 20 mg tablet, 7
lesinurad 200 mg tablet, 10
lesinurad 200 mg tablet, 30
letermovir 240 mg/12 mL injection, 12 mL vial
letermovir 240 mg tablet, 28
letermovir 480 mg/24 mL injection, 24 mL vial
letermovir 480 mg tablet, 28
letrozole 2.5 mg tablet, 10
letrozole 2.5 mg tablet, 100
letrozole 2.5 mg tablet, 30 tablets (medicinal product pack)
letrozole 2.5 mg tablet, 500
leuprorelin acetate 1 mg/0.2 mL injection, 2.8 mL vial
levetiracetam 1 g/100 mL injection, 100 mL
levetiracetam 1 g tablet, 10
levetiracetam 1 g tablet, 100
levetiracetam 1 g tablet, 30
levetiracetam 1 g tablet, 400
levetiracetam 1 g tablet, 60
levetiracetam 1.5 g/100 mL injection, 100 mL
levetiracetam 100 mg / 1 mL oral liquid, 300 mL (medicinal product pack)
levetiracetam 250 mg tablet, 100
levetiracetam 250 mg tablet, 30 tablets (medicinal product pack)
levetiracetam 250 mg tablet, 500
levetiracetam 250 mg tablet, 60
levetiracetam 500 mg/100 mL injection, 100 mL
levetiracetam 500 mg/5 mL injection, 5 mL vial
levetiracetam 500 mg/5 mL injection, 10 x 5 mL vials
levetiracetam 500 mg tablet, 10

Start Previous Page 99 of 160 Next End


Reference Sets

Reference set descriptor

Back to Start